USP (665) survey – insights and results
53:05
USP 665 and 1665 Extractables for Components in Pharmaceutical and Biopharmaceutical Manufacturing
29:33
Good Identification Practices in Non-Targeted Screening Analyses
27:24
Assuring Viral Safety of the Biopharmaceutical Process
21:21
Annual report on migration and asylum 2023 | Part 3: Research & Case Law | EMN Ireland
26:11
Challenge for Industry with new USP (665) / (1665)
38:39
Assisting Companies in the Qualification of Single-Use Materials
17:29
Annual report on migration and asylum 2023 | Part 2: Developments | EMN Ireland
55:57